Lee Ainslie Maverick Capital
Lee Ainslie is the founder of Maverick Capital, a long/short equity firm that emerged from the Tiger Management network of investors. Maverick is known for fundamental research, sector specialization among teams, and a classic hedge fund long/short structure. Ainslie’s firm remains a reference name among so-called Tiger Cub managers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Restaurant Brands International
QSR
|
+$236M |
| 2 |
Corpay
CPAY
|
+$186M |
| 3 |
Humana
HUM
|
+$160M |
| 4 |
DuPont de Nemours
DD
|
+$147M |
| 5 |
ONEM
1Life Healthcare
ONEM
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Monster Beverage
MNST
|
+$341M |
| 2 |
MDCO
Medicines Co
MDCO
|
+$185M |
| 3 |
Westlake Corp
WLK
|
+$162M |
| 4 |
T-Mobile US
TMUS
|
+$153M |
| 5 |
Centene
CNC
|
+$149M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 23.18% |
| 2 | Technology | 22.82% |
| 3 | Healthcare | 21.03% |
| 4 | Communication Services | 13.36% |
| 5 | Materials | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Ingles Markets
IMKTA
$1.61B
| $1.78M | 0.04% |
+49,173
| New | +$1.95M |
|
202
Service Corp International
SCI
$11.4B
| $1.78M | 0.04% |
+45,474
| New | +$2.11M |
|
|
ENV
203
DELISTED
ENVESTNET, INC.
ENV
| $1.77M | 0.04% |
33,006
+7,004
| +27% | +$502K |
|
|
GES
204
DELISTED
Guess Inc
GES
| $1.76M | 0.04% |
+260,050
| New | +$4.53M |
|
205
eBay
EBAY
$46.3B
| $1.75M | 0.04% |
58,393
-59,042
| -50% | -$2.06M |
|
|
EA
206
DELISTED
Electronic Arts
EA
| $1.74M | 0.04% |
+17,374
| New | +$1.83M |
|
207
Labcorp
LH
$27.3B
| $1.72M | 0.04% |
15,873
+3,503
| +28% | +$505K |
|
208
Super Micro Computer
SMCI
$24.1B
| $1.72M | 0.04% |
+808,970
| New | +$2.06M |
|
|
AGN
209
DELISTED
Allergan plc
AGN
| $1.7M | 0.04% |
9,605
-12,836
| -57% | -$2.42M |
|
210
Autodesk
ADSK
$53.6B
| $1.66M | 0.04% |
10,643
-5,563
| -34% | -$1.02M |
|
211
Cigna
CI
$73.3B
| $1.66M | 0.03% |
+9,343
| New | +$1.81M |
|
|
KSU
212
DELISTED
Kansas City Southern
KSU
| $1.64M | 0.03% |
12,898
-1,892
| -13% | -$289K |
|
213
TransUnion
TRU
$16.2B
| $1.64M | 0.03% |
+24,706
| New | +$2.13M |
|
|
WUBA
214
DELISTED
58.com Inc
WUBA
| $1.63M | 0.03% |
33,500
-33,405
| -50% | -$1.92M |
|
|
ENDP
215
DELISTED
Endo International plc
ENDP
| $1.63M | 0.03% |
+439,251
| New | +$2.22M |
|
|
TSG
216
DELISTED
The Stars Group Inc.
TSG
| $1.62M | 0.03% |
79,399
-93,363
| -54% | -$2.1M |
|
217
Pacira BioSciences
PCRX
$983M
| $1.61M | 0.03% |
48,159
-53,060
| -52% | -$2.2M |
|
218
Olin
OLN
$2.1B
| $1.61M | 0.03% |
+138,237
| New | +$2.09M |
|
219
Bio-Techne
TECH
$11.3B
| $1.59M | 0.03% |
33,632
-3,284
| -9% | -$164K |
|
|
NUAN
220
DELISTED
Nuance Communications, Inc.
NUAN
| $1.58M | 0.03% |
+94,247
| New | +$1.84M |
|
|
HZNP
221
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $1.57M | 0.03% |
53,141
-74,295
| -58% | -$2.51M |
|
222
Novartis
NVS
$302B
| $1.56M | 0.03% |
+18,918
| New | +$1.69M |
|
|
NBIS
223
Nebius Group N.V.
NBIS
$59.6B
| $1.56M | 0.03% |
+45,714
| New | +$1.89M |
|
224
Reliance Steel & Aluminium
RS
$19.8B
| $1.54M | 0.03% |
17,582
-33,234
| -65% | -$3.55M |
|
225
Warner Bros
WBD
$71.6B
| $1.52M | 0.03% |
78,175
-59,739
| -43% | -$1.64M |
|
Similar funds
Lee Ainslie's Q1 2020 Portfolio in Review
As of Q1 2020, Lee Ainslie held 565 positions worth $4.74B, down 31% from $6.87B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Lee Ainslie withdrew a net $525M in Q1 2020, closing 99 positions and reducing 138 holdings. Its most notable exit was Medicines Co, an estimated $185M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 23% of assets, up from 18% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Lee Ainslie opened a new position in 1Life Healthcare worth $101M.
- Lee Ainslie's largest Q1 2020 buy was 1Life Healthcare: 5,955,185 shares worth $101M.
- Lee Ainslie added most to Restaurant Brands International in Q1 2020, an estimated $236M increase.
- Lee Ainslie's biggest Q1 2020 reduction was Monster Beverage, cutting an estimated $341M.
- Lee Ainslie fully exited Medicines Co in Q1 2020, selling an estimated $185M.
- Lee Ainslie's ten largest holdings make up 49% of its $4.74B portfolio in Q1 2020.
- Lee Ainslie opened 228 new positions and closed 99 in Q1 2020.
- Lee Ainslie's portfolio value fell 31% quarter-over-quarter to $4.74B.
Based on Maverick Capital's 13F filing for Q1 2020, filed 15 May 2020.